Create a narrative

GeneDx Holdings Community

NasdaqGS:WGS Community

1 Narratives written by author
0 Comments on narratives written by author
29 Fair Values set on narratives written by author

GeneDx Holdings

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 7 Analysts

Expanding Pediatric Genomics Will Transform Rare Disease Diagnostics

Key Takeaways Accelerating adoption of genomics in pediatrics and enhanced AI platforms drive growth, efficiency, and margin improvement while reinforcing competitive advantage. Increasing reimbursement, enriched rare disease datasets, and global biopharma partnerships support recurring revenues, premium pricing, and high barriers to entry.

US$115.29

FV

9.6% overvalued

19.50%

Revenue growth p.a.

0

0

19

2 days ago